<DOC>
	<DOCNO>NCT02276365</DOCNO>
	<brief_summary>The objective study investigate whether drug-drug interaction BI 10773 pioglitazone co-administered multiple oral dos . Therefore , relative bioavailabilities BI 10773 pioglitazone determine drug give combination compare BI 10773 pioglitazone give alone .</brief_summary>
	<brief_title>Bioavailability BI 10773 Pioglitazone Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead ECG ( electrocardiogram ) , clinical laboratory test Age 18 50 year ( incl . ) BMI 18.5 29.9 kg/m2 ( incl . ) Signed date write informed consent prior admission study accordance GCP ( Good Clinical Practice ) local legislation Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) Intake drug long halflife ( 24 hour ) within least one month le 10 halflives respective drug prior administration trial Participation another trial investigational drug within two month prior administration trial Smoker ( 10 cigarette 3 cigar 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( 30 g/day ) Drug abuse Blood donation ( 100 mL within four week prior administration trial ) Excessive physical activity ( within one week prior administration trial ) ALT ( Alanine transaminase ) outside normal range laboratory value outside reference range clinical relevance Inability comply dietary regimen trial site Galactose lactose intolerance , galactose glucose malabsorption</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>